Abstract:Chickenpox infections are generally mild but due to their very high incidence among healthy children they give rise to considerable morbidity and occasional mortality. With the development of a varicella vaccine in the early 1970s and its progressive licensing in many countries, interest in the efficiency of varicella immunisation programmes grew. The objective of this review was to discuss the methodological aspects and results of published economic evaluations of varicella vaccination. From this, we attempted to make recommendations. A computerised search was carried out; 17 full economic evaluations of varicella vaccination were retrieved. The review identified the methodological divergences and similarities between the articles in four areas: study design, epidemiological data, economic data and model characteristics. We assessed to what extent the applied methods conform to general guidelines for the economic evaluation of healthcare interventions and compared the studies' results. The desirability of a universal vaccination programme depends on whose perspective is taken. Despite variability in data and model assumptions, the studies suggest that universal vaccination of infants is attractive to society because large savings occur from averted unproductive days for parents. For the healthcare payer, universal vaccination of infants does not generate savings. Vaccination of susceptible adolescents has been proposed by some authors as a viable alternative; the attractiveness of this is highly dependent on the negative predictive value of anamnestic screening. Targeted vaccination of healthcare workers and immunocompromised individuals appears relatively cost effective. Findings for other target groups are either contradictory or provide insufficient evidence for any unequivocal recommendations to be made. High sensitivity to vaccine price was reported in most studies. This review highlights that some aspects of these studies need to be further improved before final recommendations can be made. First, more transparency, completeness and compliance to general methodological guidelines are required. Second, because of the increasing severity of varicella with age, it is preferable and in some cases essential to use dynamic models for the assessment of universal vaccination strategies. Third, most studies focused on the strategy of vaccinating children only while their results depended heavily on disputable assumptions (regarding vaccine effectiveness and impact on herpes zoster). Since violation of these assumptions could have important adverse public health effects, we suggest pre-adolescent vaccination as a more secure alternative. This option deserves more attention in future analyses.

Chickenpox: An update

Economic evaluations of varicella vaccination programmes: a review of the literature

[Vaccines against Herpes zoster: Effectiveness, safety, and cost/benefit ratio]

Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs

Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?

Varicella vaccination in Europe: are we ready for a universal childhood programme?

[Consequences of opposition to vaccination in France and Europe. How to maintain effective vaccine coverage in 2010?]

Efficacy of varicella (VZV) vaccination: an update for the clinician

Burden of chickenpox complications in Poland, 2006 to 2021: A comprehensive registry-based study

Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study

Seroprevalence of varicella-zoster virus as measured by fluorescent antibody to membrane antigen assay and glycoprotein enzyme-linked immunosorbent assay more than 10 years after initiation of a universal vaccination program: An observational study

[Varicella vaccination: scientific reasons for a different strategic approach]

Varicella Vaccine: a Molecular Variant That May Contribute to Attenuation

Clinical and Economic Burden of Antibiotic Use Among Pediatric Patients With Varicella Infection in the Outpatient Setting: A Retrospective Cohort Analysis of Real-world Data in France

Vaccination contre la varicelle, grossesse et allaitement : un état des lieux

Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States

Parental perceptions of chickenpox and the varicella vaccine: A qualitative systematic review

How French physicians manage with a future change in the primary vaccination of infants against diphtheria, tetanus, pertussis and poliomyelitis? A qualitative study with focus groups

What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model

Clinical Profile of Hospitalized Varicella Cases From Pediatric Emergency Consultations: A Retrospective Cohort Study

Progress in the treatment and prevention of varicella